JFG
ICPT

Jefferies Financial Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Jefferies Financial Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,000,000
Closed -$37.1M – 2090
2023
Q3 		$37.1M Buy
+2,000,000
New +$22.6M 0.33% 42

Jefferies Financial Group's ICPT Position: Q4 2023 in Review

Jefferies Financial Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 2,000,000 shares — an estimated $37.1M sold.

Jefferies Financial Group first reported a position in ICPT in Q3 2023 and held it in 1 quarter. The position peaked at $37.1M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Jefferies Financial Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Jefferies Financial Group sold 2,000,000 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $37.1M.
  • Jefferies Financial Group first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
  • Jefferies Financial Group's Intercept Pharmaceuticals, Inc. position peaked at $37.1M in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Jefferies Financial Group's 13F filing for Q4 2023, filed 14 Feb 2024.